These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 9798342)

  • 61. Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy.
    Suzuki Y; Aoyama N; Minamide J; Takata K; Ogata T
    Int J Clin Oncol; 2005 Jun; 10(3):204-7. PubMed ID: 15990972
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
    Agarwala SS; Neuberg D; Park Y; Kirkwood JM
    Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy.
    Recchia F; Saggio G; Cesta A; Alesse E; Gallo R; Necozione S; Rea S
    Anticancer Res; 2005; 25(4):3149-57. PubMed ID: 16080579
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Malignant melanoma treated with natural interferons alfa and beta and DAV.
    Nagatani T; Ichiyama S; Miyakawa K; Uchiyama M
    Eur J Cancer; 1992; 28A(10):1774. PubMed ID: 1389506
    [No Abstract]   [Full Text] [Related]  

  • 65. [Intralesional therapy of melanoma metastases with recombinant interferon-beta].
    Fierlbeck G; d'Hoedt B; Stroebel W; Stutte H; Bogenschütz O; Rassner G
    Hautarzt; 1992 Jan; 43(1):16-21. PubMed ID: 1612904
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy].
    Miura H; Arai H; Matsuoka A; Yazawa K; Satoh E; Nishimura K; Honda M; Fujioka H
    Hinyokika Kiyo; 1999 Feb; 45(2):79-83. PubMed ID: 10212778
    [TBL] [Abstract][Full Text] [Related]  

  • 67. IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-alpha and DTIC.
    Konjević G; Jović V; Jurisić V; Radulović S; Jelić S; Spuzić I
    Clin Exp Metastasis; 2003; 20(7):647-55. PubMed ID: 14669796
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth.
    Hervieu A; Rébé C; Végran F; Chalmin F; Bruchard M; Vabres P; Apetoh L; Ghiringhelli F; Mignot G
    J Invest Dermatol; 2013 Feb; 133(2):499-508. PubMed ID: 22951720
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CD69 on CD56+ NK cells and response to chemoimmunotherapy in metastatic melanoma.
    Konjević G; Jović V; Vuletić A; Radulović S; Jelić S; Spuzić I
    Eur J Clin Invest; 2007 Nov; 37(11):887-96. PubMed ID: 17973783
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A case of malignant melanoma of the oral cavity alive with liver metastasis for a long period with administration of a biologic response modifier, OK432.
    Umeda M; Murata M; Suzuki H; Yanagida T; Shibuya Y; Komori T
    Kobe J Med Sci; 2010 Oct; 56(3):E140-7. PubMed ID: 21063154
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [An autopsy case of neurocutaneous melanosis associated with intracerebral malignant melanoma].
    Sawamura Y; Abe H; Murai H; Tashiro K; Doi S
    No To Shinkei; 1987 Aug; 39(8):789-95. PubMed ID: 3322333
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Basic study on human interferon-beta: Part III. The mechanisms of its antitumor effect].
    Kanamori T; Nakamura N; Tobita M; Horisawa Y; Suzuki M; Asami T; Yajima T; Nobuhara M
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2111-6. PubMed ID: 2424373
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Clinical trials of supplementary chemotherapy in cases of malignant melanoma of the skin with unfavorable prognosis after surgical treatment].
    Dobrek Z
    Wiad Lek; 1987 Feb; 40(4):237-41. PubMed ID: 3617746
    [No Abstract]   [Full Text] [Related]  

  • 74. [Adjuvant chemotherapy of malignant melanoma of the female genital organs].
    Inoue S; Shibata S; Tohya T; Munemura M; Fujisaki S; Maeyama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):135-8. PubMed ID: 3456398
    [No Abstract]   [Full Text] [Related]  

  • 75. Immune functions in melanoma patients during treatment with interferon [HuIFN-alpha (Le)] alone or in combination with cimetidine.
    Flodgren P; Malmström P; Axelsson B; Boketoft A; Borgström S; Sjögren HO
    Anticancer Res; 1985; 5(2):197-204. PubMed ID: 3994311
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapy.
    Hernberg M; Muhonen T; Turunen JP; Hahka-Kemppinen M; Pyrhönen S
    J Clin Oncol; 1996 May; 14(5):1690-6. PubMed ID: 8622089
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Topical imiquimod and intralesional interleukin-2 increase activated lymphocytes and restore the Th1/Th2 balance in patients with metastatic melanoma.
    Green DS; Dalgleish AG; Belonwu N; Fischer MD; Bodman-Smith MD
    Br J Dermatol; 2008 Sep; 159(3):606-14. PubMed ID: 18616776
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Metastatic malignant melanoma of the urinary bladder: a case report].
    Nohara T; Sakai A; Fuse H; Imamura Y
    Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):707-11. PubMed ID: 19999137
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Case of primary amelanotic malignant melanoma of the female urethra].
    Yoshii T; Horiguchi A; Shirotake S; Tobe M; Tasaki S; Hayakawa M; Sumitomo M; Asano T
    Nihon Hinyokika Gakkai Zasshi; 2010 Sep; 101(6):734-7. PubMed ID: 20954381
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phase II study of DTIC, ACNU, and vincristine combination chemotherapy for supratentorial malignant astrocytomas.
    Ikeda J; Aida T; Sawamura Y; Abe H; Kaneko S; Kashiwaba T; Kawamoto T; Mitsumori K; Saitoh H
    Neurol Med Chir (Tokyo); 1996 Aug; 36(8):555-8; discussion 558-9. PubMed ID: 8831197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.